Slfn2 Regulates Type I Interferon Responses by Modulating the NF-κB Pathway.

Area of Science:

• Immunology
• Molecular Biology
• Virology

Background:

• The Slfn (Sterile alpha motif and leucine-rich repeat containing protein) family is involved in regulating type I interferon (IFN) responses.
• The precise mechanisms by which Slfn proteins exert their regulatory functions, particularly Slfn2, remain largely unelucidated.

Purpose of the Study:

• To investigate the role of Slfn2 in type I IFN-mediated immune responses.
• To elucidate the molecular mechanisms underlying Slfn2's function in regulating IFN-stimulated genes (ISGs).

Main Methods:

• Gene targeting to disrupt the Slfn2 gene in relevant cellular or animal models.
• Analysis of gene transcription, specifically for ISGs, following Slfn2 disruption.
• Co-immunoprecipitation assays to identify Slfn2 interacting partners.
• Assessment of nuclear factor kappa B (NF-κB) signaling pathway activation.

Main Results:

• Targeted disruption of the Slfn2 gene resulted in significantly increased transcription of ISGs.
• Slfn2 was found to interact with protein phosphatase 6 regulatory subunit 1 (PPP6R1).
• This interaction led to reduced activation of type I IFN-induced NF-κB signaling, consequently decreasing ISG expression.

Conclusions:

• Slfn2 acts as a negative regulator of type I IFN responses.
• Slfn2 controls ISG expression through its interaction with PPP6R1, modulating NF-κB signaling.
• These findings reveal a novel mechanism for Slfn2 in the regulation of IFN-mediated antiviral immunity.